394 related articles for article (PubMed ID: 9974405)
1. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
Kranzhöfer A; Baker AH; George SJ; Newby AC
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein.
George SJ; Johnson JL; Angelini GD; Newby AC; Baker AH
Hum Gene Ther; 1998 Apr; 9(6):867-77. PubMed ID: 9581909
[TBL] [Abstract][Full Text] [Related]
3. Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.
George SJ; Johnson JL; Angelini GD; Jeremy JY
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2500-6. PubMed ID: 9409220
[TBL] [Abstract][Full Text] [Related]
4. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
5. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.
George SJ; Lloyd CT; Angelini GD; Newby AC; Baker AH
Circulation; 2000 Jan; 101(3):296-304. PubMed ID: 10645926
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
9. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts.
Southgate KM; Mehta D; Izzat MB; Newby AC; Angelini GD
Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1640-9. PubMed ID: 10397681
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins.
George SJ; Baker AH; Angelini GD; Newby AC
Gene Ther; 1998 Nov; 5(11):1552-60. PubMed ID: 9930309
[TBL] [Abstract][Full Text] [Related]
11. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
Ye HQ; Azar DT
Invest Ophthalmol Vis Sci; 1998 May; 39(6):913-21. PubMed ID: 9579471
[TBL] [Abstract][Full Text] [Related]
12. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein.
George SJ; Zaltsman AB; Newby AC
Cardiovasc Res; 1997 Feb; 33(2):447-59. PubMed ID: 9074710
[TBL] [Abstract][Full Text] [Related]
13. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
[TBL] [Abstract][Full Text] [Related]
14. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli.
Zaoui P; Barro C; Maynard C; Descotes JL; Maurizi-Balzan J; Cordonnier DJ; Morel F
Ren Fail; 1998 Mar; 20(2):201-9. PubMed ID: 9574444
[TBL] [Abstract][Full Text] [Related]
15. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
17. Expression of metalloproteinases and its inhibitor in later stage of rabbit neointima development.
Wang H; Liu C; Song Y; Gordon D; Alavi MZ; Moore S
Int J Mol Med; 2001 Jan; 7(1):105-12. PubMed ID: 11115618
[TBL] [Abstract][Full Text] [Related]
18. Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture.
Patterson MA; Leville CD; Hower CD; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
J Surg Res; 2001 Jan; 95(1):67-72. PubMed ID: 11120638
[TBL] [Abstract][Full Text] [Related]
19. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
20. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]